Insider Transactions in Q3 2023 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 29
2023
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
81,323
+23.72%
|
$1,138,522
$14.04 P/Share
|
Sep 29
2023
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,850
+26.33%
|
$142,200
$12.19 P/Share
|
Sep 28
2023
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+33.69%
|
$300,000
$15.96 P/Share
|
Sep 26
2023
|
Jeff Himawan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,161
+41.93%
|
$418,093
$13.87 P/Share
|
Sep 22
2023
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.44%
|
$300,000
$15.96 P/Share
|
Sep 06
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
2,165
-2.61%
|
-
|